is semaglutide better than mounjaro vs Ozempic Expert Endocrinologist Explains the Difference Mounjaro vs Ozempic | Weight-loss

Sources on Retatrutide and GLP-1/GIP/Glucagon Agonists: The New England Journal of Medicine Triple-Hormone-Receptor Agonist Retatrutide for Obesity PubMed Triple-Hormone-Receptor Agonist Retatrutide for Obesity ClinicalTrials.gov Retatrutide Phase III Study (NCT05929066) Eli Lilly Clinical Trials Retatrutide Research Programme Clinical Trials Information System (European Union) Retatrutide Study Overview Retatrutide O010-60

Tirzepatide and Semaglutide are both medications used in the management of type 2 diabetes and weight loss, but they differ in several key aspects: Mechanism of Action: Semaglutide: It is a GLP-1 receptor agonist, which means it primarily activates the GLP-1 receptors in the body

Their secretory products are stored in characterised secretory vesicles, before being secreted through the basolateral membrane by exocytosis (Reference Gunawardene, Corfe and Staton2,Reference Sternini, Anselmi and Rozengurt3)

However, those studies were done on the elderly and not on athletes, so more research needs to be done

For skin, it means microneedling or laser protocols where GHK-Cu shortens recovery and amplifies collagen response